Longitudinal analysis of topographic VEP in relapsing-remitting patients with multiple sclerosis

被引:0
|
作者
Hardmeier, M. [1 ]
Hatz, F. [1 ]
Hight, D. [2 ]
Naegelin, Y. [1 ]
Schindler, C. [3 ]
Kappos, L. [1 ]
Seeck, M. [4 ]
Michel, C. M. [5 ]
Fuhr, P. [1 ]
机构
[1] Univ Basel Hosp, Neurol, CH-4031 Basel, Switzerland
[2] Univ Auckland Hamilton, Waikato Clin Sch, Anaesthesiol, Auckland, New Zealand
[3] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[4] Univ Hosp Geneva, Neurol, Geneva, Switzerland
[5] Univ Med Sch, Fundamental Neurosci, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1013
引用
收藏
页码:517 / 517
页数:1
相关论文
共 50 条
  • [41] Cognitive Impairment in Patients with Early Relapsing-Remitting Multiple Sclerosis
    Keklikoglu, Hava Doenmez
    Yoldas, Tahir Kurtulus
    Zengin, Oezkan
    Banu Solak, Elif
    Keskin, Selda
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2010, 47 (02): : 88 - 90
  • [42] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [43] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [44] Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro
    Erakovic, Jevto Lj
    Radulovic, Ljiljana B.
    Idrizovic, Zilha A.
    Roganovic, Milovan B.
    NEUROSCIENCES, 2021, 26 (04) : 331 - 338
  • [45] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [46] Characteristics of verbal fluency in patients with relapsing-remitting multiple sclerosis
    Tyburski, E.
    Potemkowski, A.
    Chec, M.
    Soltys, A.
    Sokolowski, A.
    Kowalewski, M.
    Samochowiec, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 226 - 226
  • [47] Executive function and memory in patients with relapsing-remitting multiple sclerosis
    Cerezo Garcia, Marta
    Martin, Pilar
    Aladro Benito, Yolanda
    Balseiro Gomez, Jose Jesus
    Rueda Marcos, Almudena
    PSICOTHEMA, 2009, 21 (03) : 416 - 420
  • [48] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [49] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [50] Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
    Boldrini, Vinicius O.
    Marques, Ana M.
    Quintiliano, Raphael P. S.
    Moraes, Adriel S.
    Stella, Carla R. A. V.
    Longhini, Ana Leda F.
    Santos, Irene
    Andrade, Marilia
    Ferrari, Breno
    Damasceno, Alfredo
    Carneiro, Rafael P. D.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Santos, Leonilda M. B.
    FRONTIERS IN IMMUNOLOGY, 2022, 13